CalciMedica, Inc.
CALC
$2.30
$0.2813.61%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -25.65% | -6.47% | -45.41% | -19.32% | 8.31% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -39.40% | -13.64% | -28.95% | -2.06% | 1.41% |
| Operating Income | 39.40% | 13.64% | 28.95% | 2.06% | -1.41% |
| Income Before Tax | -28.48% | 198.69% | -152.70% | -38.91% | -50.63% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -28.48% | 198.69% | -152.70% | -38.91% | -50.63% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -28.48% | 198.69% | -152.70% | -38.91% | -50.63% |
| EBIT | 39.40% | 13.64% | 28.95% | 2.06% | -1.41% |
| EBITDA | 39.38% | 13.55% | 28.87% | 2.01% | -1.41% |
| EPS Basic | -12.66% | 188.10% | -106.76% | -2.60% | -11.79% |
| Normalized Basic EPS | -12.69% | 188.08% | -106.77% | -2.60% | -11.75% |
| EPS Diluted | -12.66% | 183.33% | -106.76% | -2.60% | -11.79% |
| Normalized Diluted EPS | -12.69% | 185.35% | -106.77% | -2.60% | -11.75% |
| Average Basic Shares Outstanding | 14.04% | 12.04% | 22.23% | 35.40% | 34.74% |
| Average Diluted Shares Outstanding | 14.04% | 15.63% | 22.23% | 35.40% | 34.74% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |